Previously, living donor liver transplantation was considered as a "high-risk, high-return"medical treat- ment due to the relatively high short-term mortality. It is our task to change "high-risk, high-return"into a "low-risk, high-return"situation. In this review article, the recent evolutions in living donor liver trans- plantation for both donors and recipients at Kyoto University such as portal vein pressure modulation, hy- brid donor operation, and perioperative management considering sarcopenia, focusing on improvement of short-term outcomes are described. Under a paradigm of "marketing and innovation", various innovations and efforts have been made over the last decade aiming at improving the short-term outcomes of bothdonors and recipients. By doing so, excellent short-term results after living donor liver transplantation have been achieved, along with a potentially epoch-making discoveries.